A detailed history of Hgk Asset Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Hgk Asset Management Inc holds 48,833 shares of JNJ stock, worth $7.05 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
48,833
Previous 49,925 2.19%
Holding current value
$7.05 Million
Previous $7.3 Million 8.44%
% of portfolio
1.49%
Previous 1.42%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$145.48 - $167.38 $158,864 - $182,778
-1,092 Reduced 2.19%
48,833 $7.91 Million
Q2 2024

Aug 06, 2024

BUY
$144.38 - $157.78 $575,498 - $628,911
3,986 Added 8.68%
49,925 $7.3 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $445,481 - $467,063
2,870 Added 6.66%
45,939 $7.27 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $107,744 - $117,571
-740 Reduced 1.69%
43,069 $6.75 Million
Q3 2023

Oct 20, 2023

SELL
$155.75 - $174.48 $62,300 - $69,792
-400 Reduced 0.9%
43,809 $6.82 Million
Q2 2023

Aug 02, 2023

SELL
$154.35 - $166.11 $125,949 - $135,545
-816 Reduced 1.81%
44,209 $7.32 Million
Q1 2023

Apr 28, 2023

BUY
$151.05 - $180.26 $1.09 Million - $1.3 Million
7,233 Added 19.14%
45,025 $6.98 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $2,403 - $2,696
15 Added 0.04%
37,792 $6.68 Million
Q3 2022

Oct 18, 2022

SELL
$161.33 - $179.52 $635,962 - $707,667
-3,942 Reduced 9.45%
37,777 $6.17 Million
Q2 2022

Jul 29, 2022

SELL
$168.19 - $186.01 $191,736 - $212,051
-1,140 Reduced 2.66%
41,719 $7.41 Million
Q1 2022

May 04, 2022

SELL
$158.14 - $179.59 $12,809 - $14,546
-81 Reduced 0.19%
42,859 $7.6 Million
Q4 2021

Feb 01, 2022

BUY
$155.93 - $173.01 $448,766 - $497,922
2,878 Added 7.18%
42,940 $7.35 Million
Q3 2021

Oct 28, 2021

BUY
$161.5 - $179.47 $31,008 - $34,458
192 Added 0.48%
40,062 $6.47 Million
Q2 2021

Jul 30, 2021

BUY
$159.48 - $171.07 $416,721 - $447,005
2,613 Added 7.01%
39,870 $6.57 Million
Q1 2021

Apr 15, 2021

BUY
$153.07 - $170.48 $232,819 - $259,300
1,521 Added 4.26%
37,257 $6.12 Million
Q4 2020

Jan 08, 2021

BUY
$137.11 - $157.38 $39,761 - $45,640
290 Added 0.82%
35,736 $5.62 Million
Q3 2020

Nov 05, 2020

SELL
$140.38 - $153.83 $1.83 Million - $2 Million
-13,019 Reduced 26.86%
35,446 $5.28 Million
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $1.01 Million - $1.22 Million
-7,863 Reduced 13.96%
48,465 $6.82 Million
Q1 2020

Apr 28, 2020

SELL
$111.14 - $153.99 $58,348 - $80,844
-525 Reduced 0.92%
56,328 $7.39 Million
Q4 2019

Jan 27, 2020

BUY
$127.5 - $146.44 $63,750 - $73,220
500 Added 0.89%
56,853 $8.29 Million
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $1.64 Million - $1.84 Million
-12,927 Reduced 18.66%
56,353 $7.29 Million
Q3 2019

Oct 24, 2019

BUY
$126.95 - $142.14 $1.63 Million - $1.83 Million
12,867 Added 22.81%
69,280 $9.57 Million
Q2 2019

Jul 23, 2019

SELL
$131.15 - $144.24 $780,735 - $858,660
-5,953 Reduced 9.55%
56,413 $7.86 Million
Q1 2019

May 07, 2019

SELL
$125.72 - $139.79 $1.47 Million - $1.64 Million
-11,712 Reduced 15.81%
62,366 $8.72 Million
Q4 2018

Jan 31, 2019

SELL
$122.84 - $147.84 $4.26 Million - $5.12 Million
-34,655 Reduced 31.87%
74,078 $9.56 Million
Q3 2018

Oct 29, 2018

BUY
$121.58 - $142.88 $1.1 Million - $1.3 Million
9,086 Added 9.12%
108,733 $0
Q2 2018

Aug 08, 2018

SELL
$119.4 - $131.76 $2.18 Million - $2.4 Million
-18,232 Reduced 15.47%
99,647 $12.1 Million
Q1 2018

May 08, 2018

SELL
$125.1 - $148.14 $882,955 - $1.05 Million
-7,058 Reduced 5.65%
117,879 $15.1 Million
Q4 2017

Feb 08, 2018

SELL
$131.22 - $143.62 $488,663 - $534,840
-3,724 Reduced 2.89%
124,937 $17.5 Million
Q3 2017

Nov 13, 2017

SELL
$129.47 - $135.38 $863,564 - $902,984
-6,670 Reduced 4.93%
128,661 $16.7 Million
Q2 2017

Aug 10, 2017

BUY
N/A
135,331
135,331 $17.9 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Hgk Asset Management Inc Portfolio

Follow Hgk Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hgk Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hgk Asset Management Inc with notifications on news.